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The characteristic spectrum from control blood shows two main lines with g values of 4-2 and 2-049. Several smaller lines can also be observed. The line at g = 2-049 may be due to the copper protein ceruloplasmin. Although no qualitative differences could be found between the spectra from controls and cancer patients, samples from patients with certain types of tumour showed a significant increase in size of the g = 2-049 signal above control values. This was most noticeably the case with Hodgkin's disease and to a lesser extent with cancers of the breast. Squamous cell carcinomata, taken as a group, did not show an elevation in average size of the g = 2-049 signal. In this latter group, however, there were some indications that the effects of chemotherapeutic treatment could be followed during the early stages of such treatment. Examples are given in which onset of treatment with various cytotoxic agents was associated with reduction in size of the g = 2-049 signal.
AT the present time a concentrated effort is being made to try to find evidence of chemical or physical alterations in the blood which may occur during the development of carcinogenesis. Such findings could be of value in assisting with diagnosis and possibly even in treatment of cancer. Many examples of work in this field have been published, e.g. that of Hughes (1971) who has studied serum concentration of a range of immunoglobulins in patients with a variety of malignant conditions; Rudman et al. (1971) have examined the plasma amino acids in human blood during acute leukaemia and Ababei, Moisiu and Chisleag (1971) have looked at glucose-6-phosphate phosphohydrolase activity in erythrocytes in both human and rat cancer cases.
Unfortunately, however, few of these studies can offer much of clinical relevance although many of them have shown very positive correlations between the substances involved and certain stages of carcinogenic process. The main difficulties seem to be of 3 types. First the specificity the reaction occurring in only a small number of cases, or with only one, or a few types of tumour. Secondly, the substances may only be found at certain limited times during carcinogenesis, and thirdly they are often extremely complex and time consuming techniques. An example can be seen in the work of Field and Caspary (1970) Although detailed studies of ESR spectra have been made from a fairly wide variety of tissues in both animals and humans, it is noticeable that detailed surveys of the ESR spectrum from human blood are lacking in the literature.
Because of the possibility of using ESR as a screening or diagnostic technique, and because of the lack of adequate data in the overall spectrum of human blood, a survey was undertaken of whole ESR spectra from both normal volunteers and patients with a range of malignant diseases.
MATERIALS AND METHODS
Sampling technique and analysis.-Samples of approximately 1 ml of whole blood were drawn from patients chosen to cover a variety of different tumours. These were all patients in the Malignant Diseases Unit of the Aberdeen Royal Infirmary. Similar samples were also drawn from the investigators, staff volunteers and volunteer patients with non-malignant conditions. These latter had all been admitted for examination and treatment for various dental complaints. With this latter group care was taken to sample blood only from cases in as normal a state as possible. Any patient receiving drugs or having recently undergone surgery was eliminated from this sample. The majority were patients being examined for mechanical injury.
In all cases the blood was withdrawn by venous puncture and was transferred directly from the syringe into a standard 3 mm cylindrical ESR quartz sample tube. It was immediately immersed in liquid nitrogen where it remained until being placed into the ESR cavity. The sample was not allowed to thaw during transfer and the cavity was for all normal examinations maintained at a temperature of -180°C by means of a cold nitrogen gas stream flowing through a dewar insert in the cavity. Spectra were obtained using a Decca X3 spectrometer operating in homodyne mode at 9270 MHz with 100 KHz field modulation and a maximum incident power of 50 mW. A modulation amplitude of 20 G peak-to-peak was normally used. A standard rectangular Decca cavity was used, operating in TE012 mode with an unloaded Q-factor of approximately 8000. The signal was normally averaged over 10 sweeps using an Intertechnique SA 40B multi-channel analyser, and finally transferred to punch tape for computer analysis. Sweeps of 0-4000 G were made on each specimen, followed by more detailed study of selected areas of the spectrum. Sizes of the signals are given as peak-to-peak heights. Since Samples were obtained from a total of 23 controls. In several cases more than one sample was removed, with intervals of at least a week between sampling. This enabled checks to be made on consistency of signal in the blood of various individuals. In one case 10 samples were removed at intervals of approximately one month throughout the period of this study. Such a series not only enables a study of consistency to be made, but also provides a check on the apparatus in addition to taking normal cavity background spectra.
Averages of all the control spectra Examination of the long spectrum normally showed only 2 obvious lines. In an attempt to identify these signals further a large sample of blood was taken and centrifuged to separate blood cells from plasma, care being taken to keep haemolysis to a minimum. A small amount of anticoagulant (heparin) had to be used but a comparison of spectra from the same volunteer with and without heparin indicated that the anticoagulant did not affect the whole blood ESR spectrum in any way. Spectra run on the 2 components separately (Fig. 3) showed that the signal at g -2005 was present in the cell fraction, this being even more clearly established in a sweep from 3.2 KG upwards, with a reduced power level, and it was present to only a very small extent in the plasma fraction. The signal at g -2 16 was part of the cavity background signal.
In the plasma the signals were at g 4-2 and g -2-049 (both of these were represented by only very small components in the cells-possibly due to the small amount of plasma left in that fraction since the cells were not washed). Nebert and Mason (1963) and by Mallard and Kent (1966) . Most workers, however, appear not to have examined this part of the spectrum. Nebert and Mason suggested that the signal is associated with high spin (ionic) iron and in their case it was localized in the rough microsomal fraction of the tumorous tissues. The plasma Ingram (1969) discusses values of 2*209 and 2-056 for this compound. We did not detect a signal in the plasma with a g value in the region of 2-2 but in view of the localization of the g = 2-049 signal in the plasma and the similarity in g value to that obtained from pure ceruloplasmin we suggest that this is a possible source of this signal. The level of copper in the plasma is sufficient to account for a signal of this size (94.3 Utg/ 100 ml plasma -Hrgovcic et al., 1968) and 96% of this copper is bound to ac2+3-globulin in the form of ceruloplasmin. This copper-containing serum enzyme acts as a ferroxidase and is the molecular link between copper and iron metabolism in the body (Frieden, 1970 (Russ and Raymunt, 1956; Gault, Stein and Aronoff, 1966) , and this could probably account for the overall elevation of the signal, if this is indeed due to ceruloplasmin. The reasons for the variations are as yet unknown since the ceruloplasmin level of the blood normally does not show any great variation in a healthy individual.
As was mentioned previously, certain samples showed signals in regions of the spectrum other than those already described. The most common of these was at approximately g = 2-1, although another was occasionally seen in the region of g 4*1. These signals did not appear However, no significant overall difference in size could be detected for this signal. Examination of the g 2-049 signal, however, did show significant differences between the average control spectrum size and the average from the tumour patient samples (in taking this latter value only data from confirmed malignancies were included, benign lesions and unconfirmed cases being omitted). The data are given in Table III . It can be seen that there is a significant difference between the average control value and that for the average of the malignancies. This being the case, it was decided to break the data down further and examine the various types of malignancy to see if any had a higher significance than others. As can be seen from the table very general classification was used. It was found that cancers of the breast, taken as a whole, showed a significant difference from the mean control value. However, neither squamous cell carcinoma nor malignant melanoma showed any significant variation from the controls. These were the only tumour types where enough data were available to make a reasonable estimate of significance. However, the data for Hodgkin's lymphoma are also included even though only 3 cases were examined. This is because, despite the small sample, the size of the g _ 2*049 signal was sufficiently elevated above that of the controls to give a very high significance to the variation.
Variation in the amplitude of a signal in this region has been reported by other workers (Swartz and Wiesner, 1972) , who found a signal in blood plasma with a g value of approximately g-205. From the shape of this signal it would appear to be the same as the g = 2-049 signal of our work. They found highly significant differences in signal size between controls and patients with bronchogenic cancer, and suggest that this is common to all cancer patients. However, they comment on the variability of this effect and the difficulties in interpretation due to the wide varieties of tumours, different stages of tumourogenesis and different clinical states of the patients concerned. These same difficulties were encountered in our work and undoubtedly gave rise to the large variability in signal size. More work in this field, along with more careful selection of the patients to be studied, could perhaps reduce the errors. Further work by the above group (Mailer, 1972, personal communication) Gulko (1961) , who showed that there is some elevation in blood copper levels in a variety of cancer patients, they would add strength to the suggestion that the g = 2 049 signal arises from ceruloplasmin.
CONCLUSIONS
As was stated in the introduction, we were hoping to find some way in which ESR could be used as a screening or diagnostic technique for cancer. Unfortunately our study of blood, although by no means complete as yet and using only a smnall number of samples, has already shown that the method reported in this paper is unlikely to fulfil the conditions requiired for mass screening for malignancies in general. There are three main difficulties to be overcome, even though significant differences have been found between blood of patients with various types of tumours and that of controls. These difficulties are (1) that the differences are in signal size rather than in signal content of the spectrum and hence not so easily observable, (2) that the size difference is a fairly small one, averaging no more than 2000, and (3) that there is a wide spread of signal size in both control and tumour groups. The technique, however, has shown indications of both diagnostic and treatment monitoring functions. In the latter case there are indications of variations of signal size with treatment, particularly during chemotherapy. As regards use as a diagnostic method, there is already good evidence that certain types of malignancy, e.g. Hodgkin's disease, show abnormal ESR signals in the blood. Although there is a wide spread of control values, such groups as breast tumours showed an overall elevation in signal size. The bimodal distribution of the control results confuses these results but if the reason for this pattern could be found then it is possible that differences from normal could appear more marked, hence making the ESR blood technique a more valuable tool.
